29.85
0.30 (1.02%)
| Penutupan Terdahulu | 29.55 |
| Buka | 29.75 |
| Jumlah Dagangan | 43,896 |
| Purata Dagangan (3B) | 49,600 |
| Modal Pasaran | 250,027,984 |
| Harga / Pendapatan (P/E TTM) | 31.76 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.51 |
| Harga / Jualan (P/S) | 2.96 |
| Harga / Buku (P/B) | 4.24 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Feb 2026 |
| Margin Keuntungan | 11.65% |
| Margin Operasi (TTM) | 13.64% |
| EPS Cair (TTM) | 0.790 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 13.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 26.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.25% |
| Nisbah Semasa (MRQ) | 5.19 |
| Aliran Tunai Operasi (OCF TTM) | 12.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 12.07 M |
| Pulangan Atas Aset (ROA TTM) | 11.04% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.56% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Electromed, Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.33 |
|
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| % Dimiliki oleh Orang Dalam | 20.96% |
| % Dimiliki oleh Institusi | 51.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Hunter Associates Investment Management Llc | 30 Sep 2025 | 117,750 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 27 Jan 2026 | Pengumuman | Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |